Zobrazeno 1 - 10
of 1 375
pro vyhledávání: '"L, de Salvo"'
Publikováno v:
European review for medical and pharmacological sciences. 26(22)
SAMITAL®, a botanical drug containing three highly standardized extracts (Vaccinium myrtillus, Macleaya cordata and Echinacea angustifolia), has shown promising results in treating or preventing oral mucositis (OM) in adult patients, but it has not
Autor:
Soledad Gallego, Meriel Jenney, Heidi Glosli, Gianni Bisogno, Daniel Orbach, Anna Kelsey, Gian L. De Salvo, Mark N. Gaze, Janet Shipley, Johannes H. M. Merks, Julia C. Chisholm, Kieran McHugh, Henry Mandeville, Veronique Minard-Colin, Ilaria Zanetti, Nadège Corradini, EpSSG members, Ludi E. Smeele, Frédéric Kolb, Andrea C. Ferrari
Publikováno v:
European Journal of Cancer, 151, 84-93. Elsevier Limited
Background/objectives The primary aim of this study was to analyse and evaluate the impact of different local treatments on the pattern of relapse in children with primary head and neck non-parameningeal (HNnPM) rhabdomyosarcoma (RMS), treated in the
Autor:
G. Moretti, Vito Amoroso, Valentina Guarneri, Carmelo Bengala, Ornella Garrone, C Rossi, Claudio Zamagni, Saverio Cinieri, Giancarlo Bisagni, Alberto Zambelli, Teresa Beninato, Laura Orlando, Ilaria Pastina, Antonio Frassoldati, Antonella Ferro, Carlo Alberto Giorgi, Maria Vittoria Dieci, Giovanna Magni, Gian L. De Salvo, Claudia Andreetta, Pierfranco Conte, Margherita Cinefra, Elisa Genovesi, Gabriella Mariani, Stefania Gori, R. Vicini
Background Despite endocrine therapy being the mainstay of treatment for hormone receptor positive (HR+)/HER2− metastatic breast cancer, patients at risk of visceral crisis or doubt for endocrine sensitivity are still offered first-line chemotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76d4450b3a90758f59efd16e05d9d7c0
https://hdl.handle.net/11380/1276273
https://hdl.handle.net/11380/1276273
Autor:
A L Di Pace, Giuseppe Simone, Ludovica Grassi, Désirée Bonci, Giovanni Muto, Antonio Addario, Simona Nanni, Devis Collura, L De Salvo, Valeria Coppola, Antonella Farsetti, Giulia Federici, Steno Sentinelli, Michele Signore, Manuela Costantini, A Cannistraci, R De Maria
Publikováno v:
Oncogene (Basingstoke) 36 (2017): 3718–3728. doi:10.1038/onc.2016.505
info:cnr-pdr/source/autori:Cannistraci, A.; Federici, G.; Addario, A.; Di Pace, A. L.; Grassi, L.; Muto, G.; Collura, D.; Signore, M.; De Salvo, L.; Sentinelli, S.; Simone, G.; Costantini, M.; Nanni, S.; Farsetti, A.; Coppola, V.; De Maria, R.; Bonci, D./titolo:C-Met%2FmiR-130b axis as novel mechanism and biomarker for castration resistance state acquisition/doi:10.1038%2Fonc.2016.505/rivista:Oncogene (Basingstoke)/anno:2017/pagina_da:3718/pagina_a:3728/intervallo_pagine:3718–3728/volume:36
info:cnr-pdr/source/autori:Cannistraci, A.; Federici, G.; Addario, A.; Di Pace, A. L.; Grassi, L.; Muto, G.; Collura, D.; Signore, M.; De Salvo, L.; Sentinelli, S.; Simone, G.; Costantini, M.; Nanni, S.; Farsetti, A.; Coppola, V.; De Maria, R.; Bonci, D./titolo:C-Met%2FmiR-130b axis as novel mechanism and biomarker for castration resistance state acquisition/doi:10.1038%2Fonc.2016.505/rivista:Oncogene (Basingstoke)/anno:2017/pagina_da:3718/pagina_a:3728/intervallo_pagine:3718–3728/volume:36
Although a significant subset of prostate tumors remain indolent during the entire life, the advanced forms are still one of the leading cause of cancer-related death. There are not reliable markers distinguishing indolent from aggressive forms. Here
Inflammatory bowel disease (IBD) is associated with dysregulated macrophage responses, such that quiescent macrophages acquire a pro-inflammatory activation state and contribute to chronic intestinal inflammation. The transcriptional events governing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::5020454e3cb1fc2ec862575bcebe6785
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3001478
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3001478
Autor:
Kern, Leonie1 (AUTHOR), Henssen, Anton1 (AUTHOR), Eggert, Angelika1 (AUTHOR), Scheer, Monika1 (AUTHOR) monika.scheer@charite.de
Publikováno v:
Cancer Medicine. Oct2024, Vol. 13 Issue 20, p1-25. 25p.
Autor:
Bamonte, Giulio1,2 (AUTHOR) giuliobamonte@hotmail.com, Iodice, Clemente Maria3 (AUTHOR) cm.iodice@gmail.com, Mastropasqua, Rodolfo4 (AUTHOR) rodolfo.mastropasqua@unich.it, Van Dijk, Elon H. C.5 (AUTHOR) e.h.c.van_dijk@lumc.nl, Appeltans, Andrea1 (AUTHOR) andrea.appeltans@gmail.com, Cicinelli, Maria Vittoria6,7 (AUTHOR) cicinelli.mariavittoria@hsr.it, Menean, Matteo6,7 (AUTHOR) menean.matteo@hsr.it, Ten Tusscher, Marcel1 (AUTHOR) mtusscher@hotmail.com, Harmer, Stuart W.8 (AUTHOR) s.harmer2@uos.ac.uk, Marolo, Paola9 (AUTHOR) paola.marolo@unito.it, Borrelli, Enrico9 (AUTHOR) enrico.borrelli@unito.it, Reibaldi, Michele9 (AUTHOR) michele.reibaldi@unito.it, Panos, Georgios D.10,11 (AUTHOR) cm.iodice@gmail.com, Motta, Lorenzo12 (AUTHOR) lorenzomotta@hotmail.com
Publikováno v:
Journal of Clinical Medicine. Oct2024, Vol. 13 Issue 20, p6052. 8p.
Autor:
Visioli, Giacomo1 (AUTHOR) giacomo.visioli@uniroma1.it, Romaniello, Annalisa1 (AUTHOR) annalisa.romaniello@uniroma1.it, Spinoglio, Leonardo1 (AUTHOR) giuseppemaria.albanese@uniroma1.it, Albanese, Giuseppe Maria1 (AUTHOR) oscarmatteo.gagliardi@uniroma1.it, Iannetti, Ludovico2 (AUTHOR) ludovicoiannetti@gmail.com, Gagliardi, Oscar Matteo1 (AUTHOR) alessandro.lambiase@uniroma1.it, Lambiase, Alessandro1,2 (AUTHOR), Gharbiya, Magda1,2 (AUTHOR) magda.gharbiya@uniroma1.it
Publikováno v:
International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 20, p11074. 14p.
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
The basic physics, results of 3–D simulations, and relevant parameters for the design of a far infrared FEL, which operates in the SASE superradiant short bunch regime, are presented. It is shown that a quite interesting device can be easily develo
Autor:
Bisogno G; Department of Women's and Children's Health, University of Padua, Padua, Italy.; Pediatric Hematology Oncology Division, University Hospital of Padua, Padua, Italy., Minard-Colin V; Department of Pediatric and Adolescent Oncology, Gustave-Roussy, Université Paris-Saclay, Villejuif, France., Haduong J; Division of Oncology, Hyundai Cancer Institute, Children's Hospital Orange County, Orange, California, USA., Zanetti I; Pediatric Hematology Oncology Division, University Hospital of Padua, Padua, Italy., Ferrari A; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy., Chisholm J; Children and Young People's Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, Surrey, UK., Heske CM; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Hladun R; Pediatric Oncology and Hematology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Jenney M; Department of Pediatric Oncology, Children's Hospital for Wales, Cardiff, UK., Merks JHM; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Venkatramani R; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Nov 20, pp. e31436. Date of Electronic Publication: 2024 Nov 20.